TransMedics Group (TMDX) Tops Q1 EPS by 16c, offers guidance.

TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of ($0.08), $0.16 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $41.6 million versus the consensus estimate of $34.59 million.
Guidance:
Sees FY'23 revenue of $160 million to $170 Million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Schwab's May activity shows margin loans nearly double
• MIND Technology (MIND) Misses Q1 EPS by 5c